Skip to Content
You are currently on the new version of our website. Access the old version .
  • Communication
  • Open Access

17 January 2025

10 Pages

Establishment of a Rapid and Convenient Fluoroimmunoassay Platform Using Antibodies Against PDL1 and HER2

,
and
1
Department of Pathology, Chungnam National University Sejong Hospital, Sejong 30099, Republic of Korea
2
Department of Biological and Chemical Engineering, Hongik University, Sejong 30016, Republic of Korea
*
Author to whom correspondence should be addressed.

Abstract

The development of accurate and high-throughput tools for cancer biomarker detection is crucial for the diagnosis, monitoring, and treatment of diseases. In this study, we developed a simple and rapid fluorescence-linked immunosorbent assay (FLISA) using fluorescent dye-conjugated antibody fragments against programmed cell death ligand 1 (PDL1) and human epithelial growth factor receptor 2 (HER2). We optimized key steps in the FLISA process, including antigen immobilization, blocking, and antibody reaction, reading the assay time to 3 h—significantly faster compared to the 23 h duration of usual FLISA. The limit of detection for the rapid FLISA in detecting PDL1 was lower than that of FLISA, and the detection of HER2 was similar between the two methods, indicating that the rapid FLISA provides a fast and accurate approach for detecting PDL1 and HER2. This robust platform can be readily adapted for various fluoroimmunoassays targeting other antigens of interest.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.